Analyst Insights - Digital Health Posts

Read our Analysts’ insights and expert opinions on the latest healthcare technology industry developments and market trends. Signify Research provides both free insights and premium insights which are only available to subscribers of "Signify Premium Insights".
Click on the premium insights link below to filter for just the premium content.

Signify Premium Insight: Volpara Acquires CRA Health in $22m Deal

Signify Premium Insights Subscription Required

11th February 2021 – Breast health company Volpara has revealed it has acquired breast cancer risk assessment company, CRA Health in a deal worth $22m. In this Insight, we explore the motivations and potential impacts of the deal.

Signify Premium Insight: COVID-19’s Impact on the Imaging IT Market

Signify Premium Insights Subscription Required

9th February 2021 – The imaging IT market has not been immune to the impact of the COVID-19 pandemic. This insight explains how the market has been affected, as well as how vendors can best react to the changing conditions.

Signify Premium Insight: Visage Maintains its Momentum with $40m Deal

Signify Premium Insights Subscription Required

February 4th 2021 – In the latest of a spate of high-profile deals, Visage Imaging has signed a $40m contract with Intermountain Healthcare. This insight assesses what the new cloud deployment means and what its potential impact could be.

Signify Premium Insight: The Options for AI Integration in Medical Imaging

Signify Premium Insights Subscription Required

3rd February 2021 – Vendors are taking different approaches to incorporating AI into their imaging workflows. Some vendors are offering AI marketplaces, while others are focusing on direct integrations of select solutions. Here, we outline the advantages and drawbacks of these different approaches.

Signify Premium Insight: COVID-19 Impact on the X-ray market

Signify Premium Insights Subscription Required

2nd February 2021 – The impact of COVID-19 on the X-ray market varied significantly across different modalities depending on their necessity in COVID-19 diagnosis. In this Premium Insight, we assess and explain those variances.